Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene

The positive link between osteoporosis and hypercholesterolemia has been documented, and bone resorption inhibitors, such as nitrogen-containing bisphosphonates (N-BP) and selective estrogen receptor modulators (SERMs), are known to reduce serum cholesterol levels. However, the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohta, Hiroaki, Uemura, Yukari, Sone, Teruki, Tanaka, Shiro, Soen, Satoshi, Mori, Satoshi, Hagino, Hiroshi, Fukunaga, Masao, Nakamura, Toshitaka, Orimo, Hajime, Shiraki, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025188/
https://www.ncbi.nlm.nih.gov/pubmed/36707436
http://dx.doi.org/10.1007/s00223-023-01060-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025188/
https://www.ncbi.nlm.nih.gov/pubmed/36707436
http://dx.doi.org/10.1007/s00223-023-01060-9

Ejemplares similares